Corrigendum to ‘Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis’ [J Hepatol 75 (2021) 865–878]
نویسندگان
چکیده
It has come to our attention that the excel files of following supplementary tables were not included during online publication article: Table S3, S4, S8, S9, S13, and S14. These have now been made available online. We apologize for any inconvenience caused. Molecular characterisation hepatocellular carcinoma in patients with non-alcoholic steatohepatitisJournal HepatologyVol. 75Issue 4PreviewNon-alcoholic steatohepatitis (NASH)-related (HCC) is increasing globally, but its molecular features are well defined. aimed identify unique traits characterising NASH-HCC compared other HCC aetiologies. Full-Text PDF
منابع مشابه
Non-invasive biomarkers in non-alcoholic steatohepatitis-induced hepatocellular carcinoma.
Non-alcoholic fatty liver disease (NAFLD) is by far the most common form of chronic liver disease worldwide, affecting adults as well as children. Under the term of NAFLD there is a wide spectrum of diseases ranging from simple steatosis to the non-alcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma (HCC). Several mechanisms have been described to infl...
متن کاملFatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
Non-alcoholic steatohepatitis (NASH) represents a risk factor for the development of hepatocellular carcinoma (HCC) and is characterized by quantitative and qualitative changes in hepatic lipids. Since elongation of fatty acids from C16 to C18 has recently been reported to promote both hepatic lipid accumulation and inflammation we aimed to investigate whether a frequently used mouse NASH model...
متن کاملNon-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
Increased prevalence of non-alcoholic fatty liver disease (NAFLD) is one of the consequences of the current obesity epidemic. NAFLD is a major form of chronic liver disease that is highly prevalent in obese and overweight adults and children. Nonalcoholic steatohepatitis (NASH) is the severe form of NAFLD, and uncontrolled inflammation as displayed in NASH has been identified as one of the key ...
متن کاملDoes hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
Non-alcoholic steatohepatitis (NASH) has been associated with hepatocellular carcinoma (HCC) often arising in histologically advanced disease when steatohepatitis is not active (cryptogenic cirrhosis). Our objective was to characterize patients with HCC and active, histologically defined steatohepatitis. Among 394 patients with HCC detected by ultrasound imaging over 8 years and staged by the B...
متن کاملHepatocellular carcinoma in patients with non-alcoholic fatty liver disease
AIM As it is not practical to perform regular screening for hepatocellular carcinoma (HCC) in all patients with non-alcoholic fatty liver disease (NAFLD), there is a need to identify NAFLD patients who are at high risk for HCC. Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+ -M2BP) has been shown to be a surrogate marker for predicting HCC as well as a liver fibrosis marker ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Hepatology
سال: 2021
ISSN: ['1600-0641', '0168-8278']
DOI: https://doi.org/10.1016/j.jhep.2021.09.014